Aetna Downgraded to “Sell” at Goldman Sachs (AET)
Posted on May 09, 2012 at 09:20 AM EDT
Healthcare benefits provider Aetna Inc. (AET) on Wednesday caught a big downgrade from analysts at Goldman Sachs. The firm said it cut its rating on AET from “Neutral” to “Sell” with a $45 price target, suggesting a small upside to the stock’s Tuesday closing price of $43.05. Goldman said it made the move because the [...]

Healthcare benefits provider Aetna Inc. (AET) on Wednesday caught a big downgrade from analysts at Goldman Sachs.

The firm said it cut its rating on AET from “Neutral” to “Sell” with a $45 price target, suggesting a small upside to the stock’s Tuesday closing price of $43.05.

Goldman said it made the move because the company’s commercial margins could continue to fall. The downgrade follows AET’s big earnings miss late last month.

Aetna shares fell $1.32, or -3.1%, in premarket trading Wednesday.

The Bottom Line
Shares of Aetna (AET) have a 1.63% dividend yield, based on last night’s closing stock price of $43.05. The stock has technical support in the $40 price area. If the shares can firm up, we see overhead resistance around the $47-$50 price levels.

Aetna Inc. (AET) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here